Frank B. Gelder, PhD

Auckland

New Zealand

Frank B. Gelder, PhD, is founding scientist at Virionyx Corporation Ltd.

Articles

The Therapeutic Vaccine Potential of MIS416 Adjuvant

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.